The Australian market?s red run came to an end today with the key index closing the midweek session higher driven by a surge in energy stocks. Openpay soared 25% after the BNPL provider outlined plans to prioritise unparalleled US market opportunities in 2022 and expansion in the UK through a partnership with Payment Assistant. A spotlight on Immuron skyrocketed 29% today after the biopharmaceutical company announced it has been awarded 6.2 million dollars for a new research agreement with the US Department of Defence to clinically evaluate a military strength dose regimen for Travelan to cure Traveler?s diarrhoea. Instagram is reportedly testing an ?edit grid? feature that will allow users to reorder their posts no matter the date they were posted.
VIDEO: Openpay soared 25% on Q2 results and global expansion plans
Video Player is loading.